Atacicept Withdrawn Phase 2 Trials for Systemic Lupus Erythematosus (SLE) Treatment

IndicationsStatusPurposePhase
WithdrawnTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01440231Atacicept Demonstrating Dose RESponSe